Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Ponich

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Crohn'S & Colitis 360|May 27, 2024
Cannabis Use in Patients With Inflammatory Bowel Disease Following Legalization of Cannabis in CanadaVadim Iablokov, Jamie Gregor, Nilesh Chande, et al.
Molecular Pharmaceutics|August 9, 2019
Crohn's Disease Is Associated with Decreased CYP3A4 and P-Glycoprotein Protein ExpressionAze Wilson, Bradley L Urquhart, Terry Ponich, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|July 27, 2013
Transcutaneous bowel sonography for inflammatory bowel disease is sensitive and specific when performed in a nonexpert low-volume North American centerMichael Sai Lai Sey, Jamie Gregor, Nilesh Chande, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|January 30, 2015
Self-Screening for Malnutrition Risk in Outpatient Inflammatory Bowel Disease Patients Using the Malnutrition Universal Screening Tool (MUST)Amindeep Sandhu, Mahmoud Mosli, Brian Yan, et al.
Inflammatory Bowel Diseases|December 8, 2011
Vedolizumab for the treatment of active ulcerative colitis: a randomized controlled phase 2 dose-ranging studyAsit Parikh, Timothy Leach, Tim Wyant, et al.
Scientific Reports|January 25, 2022
High oncostatin M predicts lack of clinical remission for patients with inflammatory bowel disease on tumor necrosis factor α antagonistsAngela Guo, Cameron Ross, Nilesh Chande, et al.
Clinical and Translational Gastroenterology|April 6, 2021
Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort StudyAze Wilson, Qian Wang, Yun-Hee Choi, et al.
Pharmacogenetics and Genomics|April 21, 2026
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel diseaseMohammed Alkhalifa, Gio R Dela Cruz, Terry Ponich, et al.
Clinical and Translational Gastroenterology|January 21, 2026
Combining Cytokine-Related Biomarkers to Better Define Tumor Necrosis Factor-α Antagonist Response in Inflammatory Bowel Disease: An Observational Cohort StudyEryn Rooney, Gio R Dela Cruz, Terry Ponich, et al.
Journal of Crohn'S & Colitis|July 18, 2025
Day 3 Oxford Criteria Predict Steroid non-response for Acute Severe Ulcerative Colitis in the Post Biologic EraSudheer K Vuyyuru, Lotus Alphonsus, Theshani Amalka De Silva, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Crohn'S & Colitis 360|May 27, 2024
Cannabis Use in Patients With Inflammatory Bowel Disease Following Legalization of Cannabis in CanadaVadim Iablokov, Jamie Gregor, Nilesh Chande, et al.
Molecular Pharmaceutics|August 9, 2019
Crohn's Disease Is Associated with Decreased CYP3A4 and P-Glycoprotein Protein ExpressionAze Wilson, Bradley L Urquhart, Terry Ponich, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|July 27, 2013
Transcutaneous bowel sonography for inflammatory bowel disease is sensitive and specific when performed in a nonexpert low-volume North American centerMichael Sai Lai Sey, Jamie Gregor, Nilesh Chande, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|January 30, 2015
Self-Screening for Malnutrition Risk in Outpatient Inflammatory Bowel Disease Patients Using the Malnutrition Universal Screening Tool (MUST)Amindeep Sandhu, Mahmoud Mosli, Brian Yan, et al.
Inflammatory Bowel Diseases|December 8, 2011
Vedolizumab for the treatment of active ulcerative colitis: a randomized controlled phase 2 dose-ranging studyAsit Parikh, Timothy Leach, Tim Wyant, et al.
Scientific Reports|January 25, 2022
High oncostatin M predicts lack of clinical remission for patients with inflammatory bowel disease on tumor necrosis factor α antagonistsAngela Guo, Cameron Ross, Nilesh Chande, et al.
Clinical and Translational Gastroenterology|April 6, 2021
Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort StudyAze Wilson, Qian Wang, Yun-Hee Choi, et al.
Pharmacogenetics and Genomics|April 21, 2026
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel diseaseMohammed Alkhalifa, Gio R Dela Cruz, Terry Ponich, et al.
Clinical and Translational Gastroenterology|January 21, 2026
Combining Cytokine-Related Biomarkers to Better Define Tumor Necrosis Factor-α Antagonist Response in Inflammatory Bowel Disease: An Observational Cohort StudyEryn Rooney, Gio R Dela Cruz, Terry Ponich, et al.
Journal of Crohn'S & Colitis|July 18, 2025
Day 3 Oxford Criteria Predict Steroid non-response for Acute Severe Ulcerative Colitis in the Post Biologic EraSudheer K Vuyyuru, Lotus Alphonsus, Theshani Amalka De Silva, et al.
Pageof 3